Mayer Davidson to Glycated Hemoglobin A
This is a "connection" page, showing publications Mayer Davidson has written about Glycated Hemoglobin A.
Connection Strength
5.843
-
Epidemiological ramifications of diagnosing diabetes with HbA1c levels. J Diabetes Complications. 2014 Jul-Aug; 28(4):464-9.
Score: 0.430
-
Diagnosing diabetes with glucose criteria: worshiping a false God. Diabetes Care. 2011 Feb; 34(2):524-6.
Score: 0.345
-
Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes Res Clin Pract. 2010 Mar; 87(3):415-21.
Score: 0.321
-
Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care. 2009 Dec; 32(12):2156-60.
Score: 0.313
-
The relationship of glycaemic control and triglycerides in patients with diabetes mellitus: a PreCIS Database Study. Diabetes Obes Metab. 2009 Feb; 11(2):118-22.
Score: 0.287
-
A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008 Jul; 93(7):2447-53.
Score: 0.285
-
Utility of A1C for diabetes screening in the 1999 2004 NHANES population. Diabetes Care. 2007 Sep; 30(9):2233-5.
Score: 0.268
-
Glycemia and risk for cardiovascular disease. Ann Intern Med. 2005 Feb 01; 142(3):227; author reply 227-8.
Score: 0.228
-
HbA(1c) measurements do not improve the detection of type 2 diabetes in a randomly selected population. Diabetes Care. 2001 Nov; 24(11):2017-8.
Score: 0.182
-
Catch-22. Diabetes Care. 2001 Feb; 24(2):414-5.
Score: 0.173
-
Revisiting the oral glucose tolerance test criterion for the diagnosis of diabetes. J Gen Intern Med. 2000 Aug; 15(8):551-5.
Score: 0.167
-
Effect of data management on a central server on HbA1c levels in insulin-requiring patients. Diabetes Care. 2000 May; 23(5):706-7.
Score: 0.164
-
Glycosylated hemoglobin as a diagnostic test for type 2 diabetes mellitus. JAMA. 2000 Feb 02; 283(5):606-7.
Score: 0.161
-
Randomized controlled trial comparing hydroxychloroquine with pioglitazone as third-line agents in type 2 diabetic patients failing metformin plus a sulfonylurea: A pilot study. J Diabetes. 2020 Jan; 12(1):91-94.
Score: 0.158
-
Review: Rapid-acting analogues do not differ from regular human insulin for mortality or HbA1c in type 2 diabetes. Ann Intern Med. 2019 04 16; 170(8):JC39.
Score: 0.152
-
Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA. 1999 Apr 07; 281(13):1203-10.
Score: 0.152
-
Delayed response to an injection of U-500 regular insulin is not rare. J Diabetes. 2019 Jul; 11(7):519-521.
Score: 0.152
-
Effectiveness of certified diabetes educators following pre-approved protocols to redesign diabetes care delivery in primary care: Results of the REMEDIES 4D trial. Contemp Clin Trials. 2018 01; 64:201-209.
Score: 0.137
-
Continuous Glucose Monitoring in Patients With Type 1 Diabetes Taking Insulin Injections. JAMA. 2017 01 24; 317(4):363-364.
Score: 0.131
-
A Reappraisal of Prediabetes. J Clin Endocrinol Metab. 2016 07; 101(7):2628-35.
Score: 0.126
-
An alternative approach to the diagnosis of diabetes with a review of the literature. Diabetes Care. 1995 Jul; 18(7):1065-71.
Score: 0.117
-
Rationale, design, and implementation of a cluster randomized trial using certified diabetes educators to intensify treatment for glycemia, blood pressure and lipid control: REMEDIES 4D. Contemp Clin Trials. 2014 Sep; 39(1):124-31.
Score: 0.110
-
Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos. Ethn Dis. 2014; 24(2):195-9.
Score: 0.106
-
High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care. 2013 Feb; 36(2):260-6.
Score: 0.097
-
A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure. Endocr Pract. 2011 May-Jun; 17(3):395-403.
Score: 0.088
-
Collaborative care for depression and chronic illnesses. N Engl J Med. 2011 03 31; 364(13):1278; author reply 1278-9.
Score: 0.087
-
U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients. Diabetes Care. 2010 Feb; 33(2):281-3.
Score: 0.079
-
Pro's and con's of the early use of insulin in the management of type 2 diabetes: a clinical evaluation. Curr Opin Endocrinol Diabetes Obes. 2009 Apr; 16(2):107-12.
Score: 0.076
-
Detailed treatment algorithms for effective nurse- and pharmacist-directed diabetes care: a personal approach. Diabetes Educ. 2009 Jan-Feb; 35(1):61-71.
Score: 0.075
-
The effectiveness of nurse- and pharmacist-directed care in diabetes disease management: a narrative review. Curr Diabetes Rev. 2007 Nov; 3(4):280-6.
Score: 0.069
-
Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetes. Diabetes Care. 2006 Jun; 29(6):1395-6.
Score: 0.062
-
Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care. 2005 Jun; 28(6):1531-3.
Score: 0.058
-
SF-36 and diabetes outcome measures. Diabetes Care. 2005 Jun; 28(6):1536-7.
Score: 0.058
-
Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus. Metabolism. 2004 Sep; 53(9):1166-73.
Score: 0.055
-
More evidence to support "outsourcing" of diabetes care. Diabetes Care. 2004 Apr; 27(4):995.
Score: 0.054
-
Lowering the criterion for impaired fasting glucose will not provide clinical benefit. Diabetes Care. 2003 Dec; 26(12):3329-30.
Score: 0.052
-
Effect of nurse-directed diabetes care in a minority population. Diabetes Care. 2003 Aug; 26(8):2281-7.
Score: 0.051
-
Editor's comment: "It ain't necessarily so". Diabetes Care. 2002 Nov; 25(11):2116.
Score: 0.049
-
Application of a diabetes managed care program. The feasibility of using nurses and a computer system to provide effective care. Diabetes Care. 1998 Jul; 21(7):1037-43.
Score: 0.036
-
Treatment of non-insulin-dependent diabetes mellitus. Mayo Clin Proc. 1997 Jan; 72(1):92.
Score: 0.033
-
A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. JAMA. 1996 Oct 16; 276(15):1246-52.
Score: 0.032
-
Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ. 2012 Feb 27; 344:e486.
Score: 0.023
-
Integrating an Automated Diabetes Management System into the family management of children with type 1 diabetes: results from a 12-month randomized controlled technology trial. Diabetes Care. 2012 Mar; 35(3):498-502.
Score: 0.023
-
The role of glucosylated serum albumin in monitoring glycemic control in stable insulin-requiring diabetic out-patients. J Clin Endocrinol Metab. 1987 Feb; 64(2):269-73.
Score: 0.016
-
Management of patients with diabetes by nurses with support of subspecialists. HMO Pract. 1995 Mar; 9(1):8-13.
Score: 0.007